How home health and hospice ownership affects care for people with dementia
The Impact of Ownership on Care for People with Dementia in Home Health and Hospice
This project looks at whether different owners of home health and hospice—nonprofits, for-profit companies, or private equity firms—change the care people with dementia get.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11265780 on NIH RePORTER |
What this research studies
From my perspective as someone affected by dementia, the researchers will compare care and outcomes for people with dementia who receive home health or hospice from different types of owners. They plan to link national Medicare and provider records to track outcomes such as emergency visits, hospitalizations, quality measures, staffing, and changes after ownership shifts. The team will analyze large databases over time to see if ownership type or private equity involvement is tied to better or worse care. Results are intended to give families and policymakers clearer information about how ownership may influence home-based and end-of-life care.
Who could benefit from this research
Good fit: Medicare beneficiaries with dementia who receive or are considering home health or hospice services are the most relevant group.
Not a fit: People without dementia or those not using home health or hospice services are unlikely to be directly included or to benefit immediately.
Why it matters
Potential benefit: If successful, the work could help families choose safer providers and support policies that protect quality care for people with dementia.
How similar studies have performed: This is a relatively new area with very limited prior research on the effects of private equity or ownership in home health and hospice for people with dementia.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Morrison, R. Sean — Icahn School of Medicine at Mount Sinai
- Study coordinator: Morrison, R. Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.